Wolverine Trading’s Alexion Pharmaceuticals ALXN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q2
Sell
-2,917
Closed -$448K 7102
2021
Q1
$448K Sell
2,917
-4,721
-62% -$730K ﹤0.01% 3866
2020
Q4
$1.19M Buy
7,638
+3,024
+66% +$389K ﹤0.01% 2205
2020
Q3
$519K Buy
+4,614
New +$498K ﹤0.01% 2779
2020
Q2
Sell
-11,151
Closed -$1.18M 5517
2020
Q1
$973K Sell
11,151
-6,880
-38% -$675K ﹤0.01% 1951
2019
Q4
$1.94M Buy
18,031
+2,954
+20% +$316K ﹤0.01% 1862
2019
Q3
$1.47M Buy
+15,077
New +$1.7M ﹤0.01% 1667
2019
Q1
Sell
-2,711
Closed -$337K 5619
2018
Q4
$264K Buy
+2,711
New +$320K ﹤0.01% 3340
2018
Q3
Sell
-24,076
Closed -$3.02M 6236
2018
Q2
$2.68M Hold
24,076
0.01% 1337
2018
Q1
$2.68M Buy
+24,076
New +$2.88M 0.01% 1337
2017
Q4
Sell
-2,413
Closed -$339K 5745
2017
Q3
$339K Sell
2,413
-9,951
-80% -$1.35M ﹤0.01% 3102
2017
Q2
$1.51M Buy
12,364
+6,529
+112% +$760K 0.01% 1420
2017
Q1
$712K Buy
+5,835
New +$752K ﹤0.01% 2012
2016
Q4
Sell
-6,887
Closed -$843K 5424
2016
Q3
$827K Buy
+6,887
New +$886K ﹤0.01% 2073

Other funds holding ALXN